Kentaro Bandobashi

AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo

Jing Yang, Takayuki Ikezoe, Chie Nishioka et al. · Blood · 2007 · 286 citations · Full text

Medicine, Oncology, Pharmacology +17

Oridonin, a diterpenoid purified from<i>Rabdosia rubescens</i>, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-κB signal pathways

Takayuki Ikezoe, Yang Yang, Kentaro Bandobashi et al. · Molecular Cancer Therapeutics · 2005 · 151 citations · Full text

Medicine, Oncology, Pharmacology +15

A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia

Takayuki Ikezoe, Jing Yang, Chie Nishioka et al. · Molecular Cancer Therapeutics · 2007 · 131 citations · Full text

Medicine, Cancer Biology, Oncology +14

Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells

Takayuki Ikezoe, Chie Nishioka, Kentaro Bandobashi et al. · Leukemia Research · 2006 · 107 citations · Full text

Life Sciences, Oncology, Pharmacology +14

HIV-1 protease inhibitor induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2

Takayuki Ikezoe, Tsuyako Saito, Kentaro Bandobashi et al. · Molecular Cancer Therapeutics · 2004 · 97 citations · Full text

Medicine, Oncology, Pharmacology +15